Bart Dzikowski
InvestorManaging Director at Novartis Venture Fund
Basel, Switzerland
Writes $5M – $10M checks · typically $7.5M
About
Bart Dzikowski is a Managing Director at the Novartis Venture Fund, where he heads Transactions & Legal. Before this role he held senior positions in Novartis' Transactions groups, which he joined in 2009, and earlier worked as a VP in investment banking at Bank of America/Merrill Lynch and as a transactions attorney at Allen & Overy in New York. He holds Juris Doctor and Civil Law degrees from McGill Law School and is a member of the New York State Bar.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- NovartisManaging Director, Head of Transactions & Legal, Novartis Venture Fundcurrent2009 — presentBasel Area, Switzerland
- Amphista Therapeutics LimitedBoard Directorcurrent2023 — presentCambridge, England, United Kingdom
- Enterprise Therapeutics (TMEM16A Acquired by Roche)Board Directorcurrent2018 — presentLondon, United Kingdom
- UZH Life Sciences FundBoard Directorcurrent2020 — presentZurich, Switzerland
- OculisBoard Director (Until Public Listing)2019 — 2023Lausanne Metropolitan Area
- Inflazome LtdBoard Director (Until Acquisition by Roche)2019 — 2020Dublin, Ireland
- F2GBoard Observer2015 — 2017London, United Kingdom
- Aeglea BioTherapeuticsBoard Observer (Until Public Listing)2014 — 2016Austin, Texas
- Sosei HeptaresBoard Observer (Until Acqusition by Sosei)2014 — 2015London, United Kingdom
- Bank of America Merrill LynchVice-President2006 — 2009New York City Metropolitan Area
- Allen & OveryAssociate2001 — 2006New York City Metropolitan Area
Skills & more
+6 more
Intellectual PropertyBusiness StrategySecurities RegulationPrivate EquityJoint VenturesMergers & Acquisitions (M&A)- Admitted to Practice Law in the State of New York — New York State Bar Association
- Admitted to practice law before the Southern Federal District Courts of New York — U.S. District Court, Southern District of New York
From Bart's professional profile.
Investments
Board seats
AmphistaEnterprise Therapeutics
Investor
RhyGaze
Per the firm's website.
Colleagues at Novartis Venture Fund
Network5
Investors connected to Bart in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Bart Dzikowski?
- Bart Dzikowski is a Managing Director at the Novartis Venture Fund, where he heads Transactions & Legal. Before this role he held senior positions in Novartis' Transactions groups, which he joined in 2009, and earlier worked as a VP in investment banking at Bank of America/Merrill Lynch and as a transactions attorney at Allen & Overy in New York. He holds Juris Doctor and Civil Law degrees from McGill Law School and is a member of the New York State Bar.
- Where does Bart Dzikowski work?
- Bart Dzikowski is Managing Director at Novartis Venture Fund.
- What does Bart Dzikowski invest in?
- Bart Dzikowski invests in Biotech.
- What check size does Bart Dzikowski write?
- Bart Dzikowski typically writes checks of $5M – $10M.
- What boards does Bart Dzikowski sit on?
- Bart Dzikowski holds tracked board seats at Amphista, Enterprise Therapeutics.
- What companies has Bart Dzikowski invested in?
- Investments tracked here include RhyGaze.
- Where did Bart Dzikowski go to school?
- Bart Dzikowski studied at McGill University (J.D. / B.C.L., Law); Queen's University (B.A. (Hons.), History & Pol. Sci.).
Same school
Also attended McGill University579
+ 573 more
Also attended Queen's University370
+ 364 more






































